In a meta-analysis 6 of eight trials with 60080 patients (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony Outcomes, REWIND, PIONEER 6, and AMPLITUDE-O) , treatment with a GLP-1 receptor agonist led to a 14% relative risk reduction in three-point MACE (HR 086 [95% CI 080093]
MEDVi advertises a money-back guarantee, but it requires at least five months of participation with documented weight loss failure
Metabolism (2016) 65(8):118395
All of the dynamics around GLP-1s, compounding shortage workarounds, and potential for DTC telehealth fallout I described last August seem to be playing out in 2025

To deliver 0.25mg: (0.25 2.5) 100 = 10 units To deliver 0.5mg: (0.5 2.5) 100 = 20 units To deliver 1mg: (1 2.5) 100 = 40 units To deliver 1.7mg: (1.7 2.5) 100 = 68 units To deliver 2mg: (2 2.5) 100 = 80 units To deliver 2.4mg: (2.4 2.5) 100 = 96 units If Your Vial Is 5mg/mL To deliver 0.25mg: (0.25 5) 100 = 5 units To deliver 0.5mg: (0.5 5) 100 = 10 units To deliver 1mg: (1 5) 100 = 20 units To deliver 1.7mg: (1.7 5) 100 = 34 units To deliver 2mg: (2 5) 100 = 40 units To deliver 2.4mg: (2.4 5) 100 = 48 units If Your Vial Is 10mg/mL To deliver 0.25mg: (0.25 10) 100 = 2.5 units To deliver 0.5mg: (0.5 10) 100 = 5 units To deliver 1mg: (1 10) 100 = 10 units To deliver 2mg: (2 10) 100 = 20 units To deliver 2.4mg: (2.4 10) 100 = 24 units Why This Matters More Than It Might Seem The stakes with semaglutide unit conversion are higher than with some other medications because the dose-response relationship is meaningful

For primary care physicians, these findings suggest that the choice of GLP-1 medication and its dosage can significantly influence the weight loss outcomes of their patients, Bartelt said